Literature DB >> 28129067

Radiologic-Pathologic Correlation of Primary and Secondary Cardiomyopathies: MR Imaging and Histopathologic Findings in Hearts from Autopsy and Transplantation.

Hiromi Hashimura1, Fumiko Kimura1, Hatsue Ishibashi-Ueda1, Yoshiaki Morita1, Masahiro Higashi1, Shintaro Nakano1, Atsushi Iguchi1, Kensuke Uotani1, Kazuro Sugimura1, Hiroaki Naito1.   

Abstract

Cardiac magnetic resonance (MR) imaging with late gadolinium enhancement (LGE) is used to detect and assess the myocardial damage seen with a variety of cardiomyopathies. Gadolinium-based contrast material accumulates in the expanded interstitial space of the myocardium. Areas with LGE correspond to replacement fibrosis, fibrofatty change, epithelioid granuloma, inflammatory cell infiltration, cardiomyocyte necrosis, and amyloid deposition-conditions that represent a focal increase in interstitial space. Areas without LGE correspond to interstitial or plexiform fibrosis, mildly degenerated cardiomyocytes, inflammatory cell infiltration, and diffuse amyloid deposition-conditions that represent diffuse increases in interstitial space. LGE MR imaging cannot depict these diffuse changes and does not enable quantitative evaluation of this increased interstitial space because on inversion-recovery MR images, the inversion time is adjusted to null the signal from normal-appearing or the least enhancing regions of the myocardium. Thus, the absence of LGE does not always indicate normal myocardial tissue. The use of current T1 mapping techniques enables one to overcome these drawbacks of LGE imaging, detect diffuse myocardial abnormalities, and perform quantitative analysis of the interstitial space. The authors describe the histopathologic and corresponding cardiac MR imaging findings of hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, cardiac sarcoidosis, giant cell myocarditis, and cardiac amyloidosis-mainly those seen on LGE MR images-as assessed by using whole-heart specimens obtained from autopsy or transplantation. ©RSNA, 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28129067     DOI: 10.1148/rg.2017160082

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  16 in total

Review 1.  Cardiac MRI Evaluation of Myocarditis.

Authors:  Lewis Hahn; Seth Kligerman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-16

Review 2.  Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome.

Authors:  Alberto Preda; Luca Liberale; Fabrizio Montecucco
Journal:  Heart Fail Rev       Date:  2021-11-18       Impact factor: 4.654

Review 3.  Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.

Authors:  Tong Liu; Deli Song; Jianzeng Dong; Pinghui Zhu; Jie Liu; Wei Liu; Xiaohai Ma; Lei Zhao; Shukuan Ling
Journal:  Front Physiol       Date:  2017-04-24       Impact factor: 4.566

Review 4.  An Intervention Target for Myocardial Fibrosis: Autophagy.

Authors:  Chunmiao Lu; Yusong Yang; Yaping Zhu; Shichao Lv; Junping Zhang
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

Review 5.  Assessment of Left Ventricular Myocardial Diseases with Cardiac Computed Tomography.

Authors:  Sung Min Ko; Tae Hoon Kim; Eun Ju Chun; Jin Young Kim; Sung Ho Hwang
Journal:  Korean J Radiol       Date:  2019-03       Impact factor: 3.500

6.  Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.

Authors:  Kongkiat Chaikriangkrai; Muhannad Aboud Abbasi; Roberto Sarnari; Ryan Dolan; Daniel Lee; Allen S Anderson; Kambiz Ghafourian; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Jane E Wilcox; Julie A Blaisdell; Clyde W Yancy; James Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2020-03-18

Review 7.  Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

8.  Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice.

Authors:  Judith J de Haan; Lena Bosch; Anouska Borgman; Marissa Bastemeijer; Maike A D Brans; Sander M van de Weg; Dominique P V de Kleijn; Joost P G Sluijter; Hamid El Azzouzi; Saskia C A de Jager
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

Review 9.  Multi-modality imaging in transthyretin amyloid cardiomyopathy.

Authors:  Bryan Paul Traynor; Aamir Shamsi; Victor Voon
Journal:  World J Cardiol       Date:  2019-11-26

Review 10.  Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes.

Authors:  Prabhat Ranjan; Rajesh Kumari; Suresh Kumar Verma
Journal:  Front Cell Dev Biol       Date:  2019-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.